Keyphrases
Murine Model
100%
Airway Hyperresponsiveness
100%
Lung Inflammation
100%
Severe Asthma
100%
Ruxolitinib
100%
Corticosteroid-resistant
100%
Asthma
28%
Asthma Patients
28%
Cyclic GMP
28%
House Dust Mite Extract
28%
Immune Response
14%
Clinical Trials
14%
Airway
14%
Health Care Costs
14%
IgE Antibody
14%
Cytokine Response
14%
Antibody Titer
14%
Hyperinflammation
14%
Difficult to Manage
14%
Cytokine Pathways
14%
Total IgE
14%
Asthma Prevalence
14%
Kinase Signaling
14%
Janus Kinase
14%
Chronic Disorders
14%
Th17 Cytokines
14%
Janus Kinase Inhibitors
14%
Anti-asthmatic
14%
Immunology and Microbiology
Respiratory Tract Allergy
100%
Pulmonary Inflammation
100%
Severe Asthma
100%
Asthma
57%
House Dust Mite Allergen Extract
28%
Immune Response
14%
Cytokine
14%
Antibody Titer
14%
Prevalence
14%
Immunoglobulin E Antibody
14%
Low Drug Dose
14%
Cytokine Response
14%
Airway
14%
Pharmacology, Toxicology and Pharmaceutical Science
Respiratory Tract Allergy
100%
Asthma
100%
Ruxolitinib
100%
Cytokine
18%
Guanosine Phosphate
18%
House Dust Mite Allergen Extract
18%
Clinical Trial
9%
Inflammation
9%
Prevalence
9%
Immunoglobulin E Antibody
9%
Janus Kinase
9%
Antiasthmatic Agent
9%
Janus Kinase Inhibitor
9%
Diseases
9%